Biopharma leader eliminates manual QA audits and cuts validation errors by 50%
The Challenge
Manual audits slow QA and increase compliance risk
A leading biopharma company faced persistent inefficiencies in their Quality Assurance (QA) validation process. Auditing Excel-based test scripts, a critical step in regulatory compliance, was entirely manual, consuming hours per document and creating bottlenecks in validation cycles.
Key pain points included:
- Time-intensive reviews: Manual audits delayed validation and slowed time-to-market
- Inconsistent outcomes: Results varied by auditor experience, causing rework and quality gaps
- Resource drain: Skilled QA professionals were stuck on repetitive tasks instead of strategic initiatives
- Limited traceability: Linking requirements to test steps and expected results was difficult to manage manually
These challenges increased compliance risks and threatened the company’s ability to maintain audit readiness during regulatory inspections.
The Objective
Modernize QA through intelligent automation
To strengthen compliance and accelerate validation, the client set out to:
- Automate audits of Excel-based test scripts for consistency and completeness
- Detect gaps and ambiguities proactively to reduce regulatory risk
- Standardize audit criteria across teams for uniform, repeatable outcomes
- Free QA resources for higher-value work by reducing manual effort
- Deliver actionable insights with severity levels and remediation guidance
The Solution
Intelligent automation to streamline QA validation and drive consistency
To transform the client’s QA process, HCLTech designed and deployed a GenAI-powered audit platform that significantly improved speed, accuracy and traceability across validation cycles. The solution enabled automated, intelligent analysis of test scripts—reducing manual effort while ensuring audit readiness.
The key capabilities included:
User-centric interface
Angular front-end: A modern, intuitive interface allowed users to upload and manage test scripts with ease.
AI-driven analysis
Zero-shot prompting: GenAI models analyzed test scripts without prior training on specific formats, detecting:
- Missing or incomplete test steps
- Ambiguous expected results
- Traceability gaps between requirements and validations
Automated reporting
Structured summaries: Findings were categorized by severity (for example, critical, major and minor) to prioritize actions
Remediation suggestions: AI-generated recommendations helped teams quickly address issues and reduce work
Exportable reports: Audit results could be exported in PDF and Excel formats for documentation and sharing for cross-team collaboration
Scalability and integration
Reusable architecture: The solution was designed to scale across departments and adapt to different test script formats
System integration: Future-ready built-in APIs capabilities enabled seamless integration with existing validation management and document control systems
Implementation approach phased for precision and scale
HCLTech adopted a structured three-phase rollout to ensure precision, adoption and long-term scalability:
- Phase 1 – Pilot and feedback: A pilot was conducted with selected QA teams to validate the AI model’s accuracy and usability
- Phase 2 – Optimization and expansion: Based on the feedback, the platform was refined and scaled to additional teams and document types
- Phase 3 – Full integration: The solution was integrated into the client’s broader validation and quality management ecosystem
The Impact
Faster audits, fewer errors, stronger compliance
The transformation delivered measurable gains:
- 30–50% reduction in validation errors, improving audit readiness and reducing regulatory findings
- 30–40% faster audits, accelerating validation cycles and reducing project delays
- Standardized audit criteria, ensuring consistency and compliance across teams
- Improved resource utilization, freeing QA professionals for strategic initiatives
- Scalable solution, adaptable for future expansion and diverse validation formats
By automating previously manual processes, the biopharma leader strengthened their compliance posture, improved operational efficiency and set a new benchmark for intelligent QA in life sciences.
